TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1, 3-galactosyltransferase and Cosmc

Molecular Medicine Reports

Volumn 15, Issue 2, 2017, Pages 969-974

  Xiao, Jun ^a   Wang, Manting ^a   Xiong, Dawei ^b   Wang, Ying ^a   Li, Qiuyue ^a   Zhou, Jing ^a   Chen, Qinkai ^a  

^a NANCHANG UNIVERSITY   (China)

^b INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

3 galactosyltransferase; Core1 1; Cosmc; IgA nephropathy; IgA1 glycosylation; Transforming growth factor 1

Indexed keywords

1 BETA1,3 GALACTOSYLTRANSFERASE; CHAPERONE; COSMC PROTEIN; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN A1; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; C1GALT1 PROTEIN, HUMAN; C1GALT1C1 PROTEIN, HUMAN; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN A; MESSENGER RNA; SIALIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LECTIN BINDING; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIALYLATION; CELL LINE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; IMMUNOGLOBULIN A NEPHROPATHY; METABOLISM;

CELL LINE; DOWN-REGULATION; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-4; MOLECULAR CHAPERONES; RNA, MESSENGER; SIALIC ACIDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85009064157     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.6084     Document Type: Article

References (46)

1. D'Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24: 179-196, 2004.
2. Barratt J, Feehally J and Smith AC: Pathogenesis of IgA nephropathy. Semin Nephrol 24: 197-217, 2004.
3. Tarelli E, Smith AC, Hendry BM, Challacombe SJ and Pouria S: Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr Res 339: 2329-2335, 2004.
4. Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG and Novak J: Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem 280: 19136-19145, 2005.
5. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, et al: Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71: 1148-1154, 2007.
6. Kokubo T, Hiki Y, Iwase H, Horii A, Tanaka A, Nishikido J, Hotta K and Kobayashi Y: Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 8: 915-919, 1997.
7. Yan Y, Xu LX, Zhang JJ, Zhang Y and Zhao MH: Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy. Clin Exp Immunol 144: 17-24, 2006.
8. Barratt J, Smith AC and Feehally J: The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology 12: 275-284, 2007.
9. Floege J: The pathogenesis of IgA nephropathy: What is new and how does it change therapeutic approaches? Am J Kidney Dis 58: 992-1004, 2011.
10. Ju T, Brewer K, D'Souza A, Cummings RD and Canfield WM: Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem 277: 178-186, 2002.
11. Ju T and Cummings RD: A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA 99: 16613-16618, 2002.
12. Allen AC, Topham PS, Harper SJ and Feehally J: Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 12: 701-706, 1997.
13. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, et al: IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118: 629-639, 2008.
14. Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, et al: Enzymatic sialylation of IgA1 O-Glycans: Implications for studies of IgA nephropathy. PLoS One 9: e99026, 2014.
15. Nagasawa R, Maruyama N, Imasawa T and Mitarai T: Role of T cells in murine IgA nephropathy. Nephrol Dial Transplant 14 (Suppl 1): S12-S13, 1999.
16. Lycke N: T cell and cytokine regulation of the IgA response. Chem Immunol 71: 209-234, 1998.
17. Chintalacharuvu SR and Emancipator SN: The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J Immunol 159: 2327-2333, 1997.
18. Yamada K, Kobayashi N, Ikeda T, Suzuki Y, Tsuge T, Horikoshi S, Emancipator SN and Tomino Y: Down-regulation of core 1 beta 1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant 25: 3890-3897, 2010.
19. Suzuki H, Raska M, Yamada K, Moldoveanu Z, Julian BA, Wyatt RJ, Tomino Y, Gharavi AG and Novak J: Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes. J Biol Chem 289: 5330-5339, 2014.
20. Yu HH, Chu KH, Yang YH, Lee JH, Wang LC, Lin YT and Chiang BL: Genetics and Immunopathogenesis of IgA Nephropathy. Clinic Rev Allerg Immunol 41: 198-213, 2011.
21. Toyabe S, Harada W and Uchiyama M: Oligoclonally expanding gammadelta T lymphocytes induce IgA switching in IgA nephropathy. Clin Exp Immunol 124: 110-117, 2001.
22. Meng H, Zhang L, E XQ, Ye F, Li H, Han C, Yamakawa M and Jin X: Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: Correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort. Transl Res 163: 8-18, 2014.
23. Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ and Chiang BL: Increased transfroming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura. Clin Exp Immunol 122: 285-290, 2000.
24. Xiao J, Cao CY, Zhou J and Wang WH: Changes in levels of Th1, Th2 and Th3 cells in peripheral blood in patients with IgA nephropathy and their significance. Prac Clin Med 13: 28-31, 2012 (In Chinese).
25. Qin W, Zhou Q, Yang LC, Li Z, Su BH, Luo H and Fan JM: Peripheral B lymphocyte beta1, 3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med 258: 467-477, 2005.
26. Xie LS, Qin W, Fan JM, Huang J, Xie XS and Li Z: The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy. Clin Invest Med 33: E5-E13, 2010.
27. de Wolff JF, Dickinson SJ, Smith AC, Molyneux K, Feehally J, Simon A and Barratt J: Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome. Clin Exp Med 9: 291-296, 2009.
28. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
29. Prud'homme GJ and Piccirillo CA: The inhibitory effects of transforming growth factor-beta-1(TGF-beta1) in autoimmune diseases. J Autoimmun 14: 23-42, 2000.
30. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, et al: Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64: 149-159, 2003.
31. Leung JC, Chan LY, Tsang AW, Liu EW, Lam MF, Tang SC and Lai KN: Anti-macrophagemigration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. Nephrol Dial Transplant 19: 1976-1985, 2004.
32. Zhong Q, Leung JC, Chan LY, Tsang AW, Chen X and Lai KN: The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy. Am J Chin Med 33: 613-626, 2005.
33. Chihara Y, Ono H, Ishimitsu T, Ono Y, Ishikawa K, Rakugi H, Ogihara T and Matsuoka H: Roles of TGF-beta 1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy. Clin Nephrol 65: 385-392, 2006.
34. Kim PH and Kagnoff MF: Transforming growth factor beta 1 increases IgA isotype switching at the clonal level. J Immunol 145: 3773-3778, 1990.
35. Cazac BB and Roes J: TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13: 443-451, 2000.
36. Boratyska M: Urine excretion of transforming growth factor-beta 1 in chronic allograft nephropathy. Ann Transplant 4: 23-28, 1999.
37. Ibelgaufts H: Cytokines and Cells Online Pathfinder Encyclopaedia (COPE). http://www.copewithcytokines.de/cope.cgi. 2007.
38. Kajdaniuk D, Marek B, Borgiel-Marek H and Kos-Kuda B: Transforming growth factor β1 (TGF-β1) in physiology and pathology. Endokrynol Pol 64: 384-396, 2013.
39. Barratt J and Feehally J: IgA nephropathy. J Am Soc Nephrol 16: 2088-2097, 2005.
40. Coppo R and Amore A: Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65: 1544-1547, 2004.
41. Julian BA and Novak J: IgA nephropathy: An update. Curr Opin Nephrol Hypertens 13: 171-179, 2004.
42. Lai KN: Pathogenesis of IgA nephropathy. Nat Rev Nephrol 8: 275-283, 2012.
43. Ju T, Brewer K, D'Souza A, Cummings RD and Canfield WM: Cloning and expression of human core 1 beta1, 3-galactosyltransferase. J Biol Chem 277: 178-186, 2002.
44. Serino G, Sallustio F, Cox SN, Pesce F and Schena FP: Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol 23: 814-824, 2012.
45. He L, Peng Y, Liu H, Yin W, Chen X, Peng X, Shao J, Liu Y and Liu F: Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy. Am J Nephrol 38: 321-332, 2013.
46. Inoue T, Sugiyama H, Hiki Y, Takiue K, Morinaga H, Kitagawa M, Maeshima Y, Fukushima K, Nishizaki K, Akagi H, et al: Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy. Clin Immunol 136: 447-455, 2010.